TG Therapeutics, Inc. (BIT:1TGTX)

TG Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	132.14	179.89	92.93	102.3	298.89	553.44
Short-Term Investments	144.1	131.11	124.58	59.37	15.88	51.99
Cash & Short-Term Investments	276.24	311	217.51	161.68	314.76	605.43
Cash Growth	31.68%	42.98%	34.53%	-48.63%	-48.01%	331.11%
Accounts Receivable	190.12	129.19	51.09	-	1.39	-
Receivables	190.12	129.19	51.09	-	1.39	-
Inventory	157.76	110.46	39.82	-	-	-
Other Current Assets	20.39	15.72	9.52	6.6	14.81	6.31
Total Current Assets	644.51	566.36	317.94	168.27	330.97	611.74
Property, Plant & Equipment	6.93	7.15	8.05	9.2	9.23	9.79
Long-Term Investments	1.91	0.81	-	12.4	35.53	-
Goodwill	-	-	-	0.8	0.8	0.8
Long-Term Deferred Charges	-	-	-	1.63	1.84	2.05
Other Long-Term Assets	3.35	3.37	3.59	1.27	1.26	1.26
Total Assets	656.69	577.69	329.59	193.57	379.63	625.64
Accounts Payable	93.83	26.3	29.27	42.02	50.89	37.01
Accrued Expenses	5.14	15.19	12.17	8.43	10.17	8.46
Current Portion of Long-Term Debt	0.87	0.66	0.36	0.24	1.34	23.12
Current Portion of Leases	1.12	1.16	1.45	1.58	1.44	1.67
Current Unearned Revenue	17.08	11.41	0.15	-	0.2	0.2
Other Current Liabilities	42.17	35.97	10.32	0.93	1.35	17.1
Total Current Liabilities	160.21	90.68	53.72	53.2	65.38	87.55
Long-Term Debt	244.73	244.43	100.12	71.14	66.79	7.72
Long-Term Leases	7.86	8.13	9.23	10.34	9.85	10.41
Long-Term Unearned Revenue	6.6	12.09	6.02	0.31	0.46	0.61
Total Liabilities	419.4	355.33	169.09	134.99	142.48	106.29
Common Stock	0.16	0.16	0.15	0.15	0.14	0.14
Additional Paid-In Capital	1,776	1,760	1,713	1,586	1,566	1,500
Retained Earnings	-1,524	-1,529	-1,553	-1,527	-1,329	-980.6
Treasury Stock	-15.12	-8.99	-0.23	-0.23	-0.23	-0.23
Shareholders' Equity	237.29	222.36	160.5	58.59	237.15	519.35
Total Liabilities & Equity	656.69	577.69	329.59	193.57	379.63	625.64
Total Debt	254.58	254.38	111.15	83.3	79.41	42.91
Net Cash (Debt)	21.66	56.62	106.36	78.38	235.36	562.51
Net Cash Growth	-77.85%	-46.76%	35.70%	-66.70%	-58.16%	465.67%
Net Cash Per Share	0.13	0.35	0.72	0.58	1.78	4.88
Filing Date Shares Outstanding	145.82	145.23	144.78	137.63	130.79	129.8
Total Common Shares Outstanding	145.23	143.99	141.79	137.65	131.22	129.79
Working Capital	484.3	475.68	264.22	115.07	265.58	524.19
Book Value Per Share	1.63	1.54	1.13	0.43	1.81	4.00
Tangible Book Value	237.29	222.36	160.5	57.79	236.35	518.55
Tangible Book Value Per Share	1.63	1.54	1.13	0.42	1.80	4.00

Source: S&P Global Market Intelligence. Standard template. Financial Sources.